Alle News zu Großbritannien      9717.4555     +0.12%     (FTSE 100 Kurs)

 

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

APTIV HLDS LTD (APTV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....

Mining company SolGold Plc, which is seeking to develop a copper mine in Ecuador, said it's rejected a second takeover offer from China's Jiangxi Copper Co....

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

Fuller, Smith & Turner PLC: Transaction in own shares...

Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision that will put pressure on the government to overrule the advice....

The Boohoo share price has gone parabolic as losses narrow, and the company's turnaround gains momentum. But I'm not getting too excited just yet. The post How on earth has the Boohoo share price exploded 88% since yesterday? appeared first on The Motley Fool UK....

Das Kabinett hat sich auf weniger strenge Regeln beim Verbrenner-Aus verständigt, der Kanzler hat deswegen der EU geschrieben. Er bat die EU-Kommission um Änderungen....

Atlas Metals Group PLC on Friday said it updated the competent person's report in relation to its proposed acquisition of...

Hydrogen Utopia International PLC shares jumped on Friday as it said its relationship with Saudi Investment Recycling Co has...

DEC's acquisition of Canvas Energy lifts production, expands its Oklahoma position and strengthens financial flexibility through a major ABS deal....

SHEL deepens its Southeast Asia presence as Brunei Shell Petroleum awards ADES a major offshore drilling contract in Brunei....

NEW YORK, NY / ACCESS Newswire / November 28, 2025 / The rare earth sector has spent the past decade trying to answer a question that never had a reliable solution. How do you prove where a mineral......

Max Kettner, HSBC chief multi-asset strategist, says the December Federal Reserve interest rate decision won't have much an impact on risk assets. He says earnings are more important. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)...

Property tycoon Michael Fuchs is facing a jail term after a London judge, overseeing a £37.5 million ($49.6 million) divorce award, ruled he was in contempt of court for breaching orders over the sale of real estate assets...

Für seinen Angriffskrieg gegen die Ukraine wirbt Russland auch Ausländer an - oft unter Vorwänden. Im Donbass sollen mehr als ein Dutzend Südafrikaner festsitzen. Die südafrikanischen Behörden ermitteln in diesem Zusammenhang gegen eine Abgeordnete. Diese zieht nun Konsequenzen....

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

MIAMI, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN), today announced the pricing of a public offering of 80,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) at an offering price of $0.75 per share of common stock (or per pre-funded warrant in lieu thereof). The public offering was led by healthcare-dedicated investors, including Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia Threadneedle Investments, Adage Capital Partners, and Squadron Capital Management....

Um den gesamten Artikel unter apnews.com zu lesen, klicken Sie bitte auf die Überschrift...